Farrell DJ - Search Results

1

Rifaximin in the treatment of irritable bowel syndrome: is there a high risk for development of antimicrobial resistance?

Farrell DJ. Farrell DJ. J Clin Gastroenterol. 2013 Mar;47(3):205-11. doi: 10.1097/MCG.0b013e31827559a3. J Clin Gastroenterol. 2013. PMID: 23340064 Review.

2

Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada.

Marchand-Austin A, Memari N, Patel SN, Tang P, Deeks SL, Jamieson FB, Crowcroft NS, Farrell DJ. Marchand-Austin A, et al. Among authors: farrell dj. Int J Antimicrob Agents. 2014 Jul;44(1):82-4. doi: 10.1016/j.ijantimicag.2014.04.001. Epub 2014 May 2. Int J Antimicrob Agents. 2014. PMID: 24837412 No abstract available.

3

Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012).

Sader HS, Farrell DJ, Flamm RK, Jones RN. Sader HS, et al. Among authors: farrell dj. Antimicrob Agents Chemother. 2014;58(4):2274-80. doi: 10.1128/AAC.02684-13. Epub 2014 Feb 3. Antimicrob Agents Chemother. 2014. PMID: 24492361 Free PMC article.

4

Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groups.

Sader HS, Flamm RK, Farrell DJ, Jones RN. Sader HS, et al. Among authors: farrell dj. Antimicrob Agents Chemother. 2013 Dec;57(12):6378-80. doi: 10.1128/AAC.01906-13. Epub 2013 Sep 30. Antimicrob Agents Chemother. 2013. PMID: 24080651 Free PMC article.

5

Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).

Farrell DJ, Flamm RK, Sader HS, Jones RN. Farrell DJ, et al. Int J Antimicrob Agents. 2013 Apr;41(4):337-42. doi: 10.1016/j.ijantimicag.2012.12.013. Epub 2013 Mar 5. Int J Antimicrob Agents. 2013. PMID: 23466338

6

Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia.

Biedenbach DJ, Farrell DJ, Flamm RK, Liverman LC, McIntyre G, Jones RN. Biedenbach DJ, et al. Among authors: farrell dj. Int J Antimicrob Agents. 2012 Apr;39(4):321-5. doi: 10.1016/j.ijantimicag.2011.11.016. Epub 2012 Feb 4. Int J Antimicrob Agents. 2012. PMID: 22306239

7

In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile.

Farrell DJ, Putnam SD, Biedenbach DJ, Moro L, Bozzella R, Celasco G, Jones RN. Farrell DJ, et al. Antimicrob Agents Chemother. 2011 Mar;55(3):992-6. doi: 10.1128/AAC.00688-10. Epub 2010 Dec 13. Antimicrob Agents Chemother. 2011. PMID: 21149623 Free PMC article.

8

Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres.

Sader HS, Farrell DJ, Jones RN. Sader HS, et al. Among authors: farrell dj. Int J Antimicrob Agents. 2010 Jul;36(1):28-32. doi: 10.1016/j.ijantimicag.2010.03.016. Epub 2010 May 4. Int J Antimicrob Agents. 2010. PMID: 20444576

9

Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.

Farrell DJ, Sader HS, Castanheira M, Biedenbach DJ, Rhomberg PR, Jones RN. Farrell DJ, et al. Int J Antimicrob Agents. 2010 Jun;35(6):537-43. doi: 10.1016/j.ijantimicag.2010.01.026. Epub 2010 Mar 7. Int J Antimicrob Agents. 2010. PMID: 20211548

10

Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.

Farrell DJ, File TM, Jenkins SG. Farrell DJ, et al. J Clin Microbiol. 2007 Feb;45(2):290-3. doi: 10.1128/JCM.01653-06. Epub 2006 Nov 8. J Clin Microbiol. 2007. PMID: 17093012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results